The WHO office in Muscat, in collaboration with the Ministry of Health, Sultan Qaboos University and the WHO regional office in the Middle East, conducted a seminar on clinical trials and medical research ethics, in the presence of Dr. Mona Al-Saadoun, Dean of the College of Medicine and Health Sciences at Sultan Qaboos University and Dr. Jan Jabbour, WHO Global Health Representative in the Sultanate of Oman and Dr. Halima bint Qalam Al Hinaiah, Director General of the General Directorate of Planning and Studies at the Ministry of Health.
The workshop, which is the first of its kind in the Middle East region in terms of clinical trials and medical research ethics, targeted researchers, physicians and medical assistants of health research specialists from all over the Sultanate of Oman, and implemented by experts from the WHO Regional Office.
The workshop aimed to share and discuss the concepts and applications of the study models, with a particular focus on experimental designs, in addition to identifying key aspects related to research ethics for the application of new clinical trials, reviewing informed consent forms for clinical trials of all stages, and understanding of clinical trial monitoring methodology, including data and panel security, as well as understanding the legal and ethical aspects of data ownership by defining data protection guidelines in national and international level.
The seminar opened with a speech by Dr. to improve the knowledge that supports studies at national, regional and international level and that contributes to filling scientific gaps in all areas of health.
The representative of the World Health Organization in the Sultanate of Oman stressed that this seminar is only a cornerstone for future studies, taking into account the ethics of research through partnership with the community and consideration of social values.
He also stated that this seminar is the first of its kind in the Eastern Mediterranean region and hoped, as a representative of the World Health Organization, that an initiative for clinical trials and medical research ethics would be launched from the Sultanate’s land. of Oman to promote this kind of research, especially as it attracts great interest from senior health officials and academics in the Sultanate At the head of them is His Excellency Dr. Ahmed bin Mohammed bin Obaid Al-Saidi, Minister of Health.
Dear Dr. Mona Al-Saadoun praised the efforts made for the implementation of this seminar and thanked the participants for their interest in participating, given the scientific importance of the seminar in the field of clinical trials and ethics and the approval of medical research, hoping for them. to make the most of its proposed axes.
Al-Sadoun stated that clinical trials are basic research studies aimed at evaluating medical, surgical, or behavioral intervention, and thus enable scientists and researchers to explore the safety and effectiveness of new treatment methods, new diagnostic methods, preventive measures, etc. and costly but necessary process for medical progress, it is important to ensure that clinical trials are scientifically designed, performed, implemented, monitored, reviewed, recorded, analyzed, and reported scientifically.
For her part, Dr. Halima bint Qalam Al-Hinaiah said that the Ministry of Health pays special attention to perfecting the knowledge of health care providers and developing their research skills in the health sector, which will contribute to achieving one of the components of health research. concerned with setting priorities for progress in the medical and pharmaceutical fields in line with Oman’s vision. 2040.
Al Hanaia indicated that this workshop will enable participants to understand the basics of clinical trial design, the ethics of randomized controlled trials (RCTs), and good clinical and ethical practices in Oman.
The axes of the episode started by talking about the participation and discussion of concepts and applications of study designs, with a special focus on experimental designs, where Dr. Ahmed Mandeel, Research and Innovation Coordinator at the Eastern Mediterranean Regional Office at the World Health Organization, reviewed examples of study models with an overview of a specific reference for randomized controlled trials. .
While Dr. Arshad Altaf, Technical Officer, Development and Research Development at the Regional Office for the Eastern Mediterranean at the World Health Organization, on the second axis touched on the foundations and ethics of randomized controlled trials, their control mechanism, principles. and the procedures at the various stages through which scientific research goes, even achieving accreditation and approval; And research recommendations to continue and follow up or conclude.
The seminar programs concluded with questions and discussions between participants and implementers and a review of the database for collecting data from randomized controlled and controlled trials, such as concepts, terminology, data collection methods, reporting adverse events. , the need for periodic evaluation. , risks and rewards, reliability and validity, entitlement and retention of participants, integrity and control of data, and intellectual property. , and advocate for participants in these clinical trials and studies.
At the end, the participants were thanked for their participation, active participation, evaluation of the content of the workshop and presentation of the closing remarks for the workshop.